EBITDA Summary of Teyi Pharmaceutical Group Co.,Ltd

Teyi Pharmaceutical Group Co.,Ltd's latest annual EBITDA in 2023 was 369.46 Million CNY , up 31.28% from previous year.
Teyi Pharmaceutical Group Co.,Ltd's latest quarterly EBITDA in 2024 Q2 was 4.23 Million CNY , down -85.18% from previous quarter.
Teyi Pharmaceutical Group Co.,Ltd reported an annual EBITDA of 277.98 Million CNY in 2022, up 10.55% from previous year.
Teyi Pharmaceutical Group Co.,Ltd reported an annual EBITDA of 228.31 Million CNY in 2021, up 46.28% from previous year.
Teyi Pharmaceutical Group Co.,Ltd reported a quarterly EBITDA of 4.23 Million CNY for 2024 Q2, down -85.18% from previous quarter.
Teyi Pharmaceutical Group Co.,Ltd reported a quarterly EBITDA of 11.04 Million CNY for 2024 Q1, down -70.53% from previous quarter.

Annual EBITDA Chart of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Historical Annual EBITDA of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	369.46 Million CNY	31.28%
2022	277.98 Million CNY	10.55%
2021	228.31 Million CNY	46.28%
2020	147.59 Million CNY	-40.18%
2019	269.43 Million CNY	9.74%
2018	260.19 Million CNY	51.48%
2017	173.75 Million CNY	11.07%
2016	155.04 Million CNY	36.27%
2015	114.14 Million CNY	27.52%
2014	102.64 Million CNY	-10.7%
2013	100.73 Million CNY	0.42%
2012	98.43 Million CNY	14.09%
2011	88.27 Million CNY	44.89%
2010	60.56 Million CNY	71.57%
2009	34.86 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	1.73 Million CNY	-59.04%
2024 Q2	4.23 Million CNY	-85.18%
2024 Q1	11.04 Million CNY	-70.53%
2023 Q1	128.24 Million CNY	40.41%
2023 Q3	45.35 Million CNY	-22.54%
2023 Q4	96.92 Million CNY	113.7%
2023 FY	- CNY	31.28%
2023 Q2	58.55 Million CNY	-54.34%
2022 Q4	91.33 Million CNY	111.81%
2022 Q3	43.12 Million CNY	40.75%
2022 Q2	30.63 Million CNY	-50.43%
2022 FY	- CNY	10.55%
2022 Q1	61.79 Million CNY	8.59%
2021 Q2	44.09 Million CNY	-31.3%
2021 Q4	56.91 Million CNY	57.1%
2021 FY	- CNY	46.28%
2021 Q1	64.19 Million CNY	23.7%
2021 Q3	36.22 Million CNY	-17.85%
2020 Q1	50.58 Million CNY	7.13%
2020 Q2	11.47 Million CNY	-77.31%
2020 FY	- CNY	-40.18%
2020 Q3	7.78 Million CNY	-32.19%
2020 Q4	51.89 Million CNY	566.84%
2019 Q1	66.74 Million CNY	46.78%
2019 FY	- CNY	9.74%
2019 Q4	47.22 Million CNY	-18.62%
2019 Q3	58.02 Million CNY	-18.56%
2019 Q2	71.24 Million CNY	6.74%
2018 Q1	34.29 Million CNY	8.1%
2018 FY	- CNY	51.48%
2018 Q4	45.47 Million CNY	-29.18%
2018 Q3	64.21 Million CNY	-16.72%
2018 Q2	77.1 Million CNY	124.85%
2017 FY	- CNY	11.07%
2017 Q3	36.12 Million CNY	-22.47%
2017 Q4	31.72 Million CNY	-12.18%
2017 Q2	46.59 Million CNY	81.74%
2017 Q1	25.63 Million CNY	-20.12%
2016 Q4	32.09 Million CNY	6.7%
2016 Q3	30.08 Million CNY	-11.55%
2016 Q2	34 Million CNY	23.25%
2016 FY	- CNY	36.27%
2016 Q1	27.59 Million CNY	-1.65%
2015 FY	- CNY	27.52%
2015 Q4	28.05 Million CNY	3.68%
2015 Q3	27.05 Million CNY	16.83%
2015 Q2	23.15 Million CNY	-9.89%
2015 Q1	25.7 Million CNY	85.94%
2014 Q3	13.39 Million CNY	-90.92%
2014 FY	- CNY	-10.7%
2014 Q2	147.49 Million CNY	460.34%
2014 Q4	13.82 Million CNY	3.18%
2014 Q1	26.32 Million CNY	26.7%
2013 Q4	20.77 Million CNY	-11.98%
2013 Q1	77.95 Million CNY	0.0%
2013 Q2	92.79 Million CNY	19.03%
2013 Q3	23.6 Million CNY	-74.56%
2013 FY	- CNY	0.42%
2012 FY	- CNY	14.09%
2011 FY	- CNY	44.89%
2010 FY	- CNY	71.57%
2009 FY	- CNY	0.0%

Peer EBITDA Comparison of Teyi Pharmaceutical Group Co.,Ltd

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	361.083%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	4.941%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	76.001%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	88.796%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	-142.753%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	-494.155%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	80.331%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	93.939%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	79.382%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	-179.068%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	-398.972%
Dezhan Healthcare Company Limited	219.36 Million CNY	-68.427%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	-48.004%
Jiuzhitang Co., Ltd.	460.28 Million CNY	19.731%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	82.632%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	60.921%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	-319.893%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	-6.138%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	18.582%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	-160.905%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	-196.235%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	-6.96%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	1284.262%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	427.695%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	73.394%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	-212.607%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	-122.022%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	-71.825%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	14.407%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	48.068%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	-289.92%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	30.157%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	258.15%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	-56.39%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	-2973.111%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	164.513%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	3.564%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	293.579%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	-4696.333%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	-320.084%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	-19.437%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	-91.887%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	601.598%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	66.277%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	15.111%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	2.978%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	11.529%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	939.804%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	46.923%
Tibet AIM Pharm. Inc.	50.76 Million CNY	-627.835%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	71.472%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	73.59%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	56.12%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	-23.096%
Xiamen Kingdomway Group Company	588.78 Million CNY	37.25%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	-190.767%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	60.621%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	76.115%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	-34.211%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	92.119%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	-31.639%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	-32.582%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	-5.497%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	-176.683%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	69.12%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	-69.888%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	43.508%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	22.605%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	-384.139%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	92.96%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	20.381%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	1.564%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	39.461%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	92.905%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	-189.276%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	-61.407%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	-625.008%
Huadong Medicine Co., Ltd	4.61 Billion CNY	91.998%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	72.409%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	-101.163%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	-172.931%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	64.712%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	-913.74%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	-280.885%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	64.835%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	-193.579%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	57.236%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	215.426%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	223.728%

Global Stocks Search

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

EBITDA Summary of Teyi Pharmaceutical Group Co.,Ltd

Annual EBITDA Chart of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Historical Annual EBITDA of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Peer EBITDA Comparison of Teyi Pharmaceutical Group Co.,Ltd